haemangioblastoma
hemangioblastoma

Böhling T, Plate KH, Haltia MJ, et al.: Von Hippel-Lindau disease and capillary haemangioblastoma.

The treatment for hemangioblastoma is surgical excision of the tumour.

The two doctors are credited with coining the term "hemangioblastoma".

Hemangioblastoma are the rarest central nervous system tumours, accounting for less than 2%.

On a scan, hemangioblastoma shows as a well-defined, black region in the cerebellum with a white nodule on the wall.

Capillary hemangioblastoma.

In VHL disease, hemangioblastoma is the most common cause of death, followed by renal cell carcinoma.

In individuals with a family history of VHL disease, one hemangioblastoma, pheochromocytoma or renal cell carcinoma may be sufficient to make a diagnosis.

Pleomorphic xanthoastrocytoma, dysembryoplastic neuroepithelial tumors, juvenile pilocytic astrocytoma, and hemangioblastoma are well-established, pediatric brain cancer tumors that are often confused with astroblastoma patients.

CAPILLARY HEMANGIOBLASTOMA (WHO grade I) occurs sporadically and is associated with the familial tumor syndrome von Hippel-Lindau (VHL) disease.

The outcome for hemangioblastoma is very good, if surgical extraction of the tumor can be achieved; excision is possible in most cases and permanent neurologic deficit is uncommon and can be avoided altogether if the tumor is diagnosed and treated early.

Older statistics taken from the first 23 plaintiffs indicated that nineteen had or have brain or nerve cancer, nine had or have glioblastoma multiforme, five had or have oligodendroglioma, two had or have meningioma, and one each had or has schwannoma and hemangioblastoma.